Delaware SB298 amends state law to clarify hemp and hemp-derived cannabinoid product definitions and testing methods.
Delaware SB298 amends Titles 3 and 16 of the Delaware Code to clarify the definitions and testing methods for hemp and hemp-derived cannabinoid products (HDCPs). The bill specifies that hemp and HDCPs with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis are not considered marijuana or controlled substances. It mandates that the determination of whether a product is hemp or marijuana must be based on the delta-9 tetrahydrocannabinol concentration and requires the use of scientifically validated testing methods.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.